Advertisement

Table of Contents

May 01, 1982; Volume 21,Issue 3

You have access
beta-Diethylaminoethyl-2, 2-diphenylpentanoate (SKF 525-A)-mediated translocation of uterine estrogen receptor from the cytosolic to the nuclear compartment in isolated rat uteri.
W H Bulger and D Kupfer

Molecular Pharmacology May 1982, 21 (3) 533-537;
You have access
Morphine allosterically modulates the binding of [3H]leucine enkephalin to a particulate fraction of rat brain.
R B Rothman and T C Westfall

Molecular Pharmacology May 1982, 21 (3) 538-547;
You have access
Allosteric coupling between morphine and enkephalin receptors in vitro.
R B Rothman and T C Westfall

Molecular Pharmacology May 1982, 21 (3) 548-557;
You have access
Dimeric enkephalins display enhanced affinity and selectivity for the delta opiate receptor.
Y Shimohigashi, T Costa, S Matsuura, H C Chen and D Rodbard

Molecular Pharmacology May 1982, 21 (3) 558-563;
You have access
The opiate receptor-binding interactions of opiate alkaloids and of an opioid peptide in rat brain membranes. Selection by manganese ions and by cholic acid (sodium salt) and minimalization of cross-reaction in vitro.
Y Kouakou, J M Zajac, C Moisand and J C Meunier

Molecular Pharmacology May 1982, 21 (3) 564-569;
You have access
Differential modification of the interaction of cardiac muscarinic cholinergic and beta-adrenergic receptors with a guanine nucleotide binding component(s).
T K Harden, A G Scheer and M M Smith

Molecular Pharmacology May 1982, 21 (3) 570-580;
You have access
Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
M Waelbroeck, P Robberecht, P Chatelain and J Christophe

Molecular Pharmacology May 1982, 21 (3) 581-588;
You have access
Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy.
P Robberecht, M Waelbroeck, M Claeys, A N Huu, P Chatelain and J Christophe

Molecular Pharmacology May 1982, 21 (3) 589-593;
You have access
Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide.
B Ringdahl, F J Ehler and D J Jenden

Molecular Pharmacology May 1982, 21 (3) 594-599;
You have access
Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
J J Mooney, W C Horne, R I Handin, J J Schildkraut and R W Alexander

Molecular Pharmacology May 1982, 21 (3) 600-608;
You have access
Sodium ion modulates agonist and antagonist interactions with the human platelet alpha 2-adrenergic receptor in membrane and solubilized preparations.
L E Limbird, J L Speck and S K Smith

Molecular Pharmacology May 1982, 21 (3) 609-617;
You have access
Heterogeneity of brain benzodiazepine receptors demonstrated by [3H]propyl beta-carboline-3-carboxylate binding.
J D Hirsch, R L Kochman and P R Sumner

Molecular Pharmacology May 1982, 21 (3) 618-628;
You have access
Structural and conformational properties of peptides interacting with the glutathione receptor of hydra.
M H Cobb, W Heagy, J Danner, H M Lenhoff and G R Marshall

Molecular Pharmacology May 1982, 21 (3) 629-636;
You have access
Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects.
L G Aguayo, J E Warnick, S Maayani, S D Glick, H Weinstein and E X Albuquerque

Molecular Pharmacology May 1982, 21 (3) 637-647;
You have access
Alpha 2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets.
S Yamazaki, T Katada and M Ui

Molecular Pharmacology May 1982, 21 (3) 648-653;
You have access
The relationship between the carbachol stimulatory effect on cyclic GMP content and activation by fatty acid hydroperoxides of a soluble guanylate cyclase in the guinea pig myometrium.
D Leiber and S Harbon

Molecular Pharmacology May 1982, 21 (3) 654-663;
You have access
Stimulation of neuroblastoma adenylate cyclase by arachidonic acid metabolites.
A C Howlett

Molecular Pharmacology May 1982, 21 (3) 664-670;
You have access
Histamine-mediated adenylate cyclase stimulation in human myocardium.
M R Bristow, R Cubicciotti, R Ginsburg, E B Stinson and C Johnson

Molecular Pharmacology May 1982, 21 (3) 671-679;
You have access
Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.
A M Siegl, J W Daly and J B Smith

Molecular Pharmacology May 1982, 21 (3) 680-687;
You have access
The formation of diarachidonyl diglyceride by rat neutrophils.
M I Siegel, R T McConnell, D A Brent, P Chandrasurin, R D Macfarlane and C J McNeal

Molecular Pharmacology May 1982, 21 (3) 688-693;
You have access
Movement of free cholesterol from lipoproteins or lipid vesicles into erythrocytes. Acceleration by ethanol in vitro.
C K Daniels and D B Goldstein

Molecular Pharmacology May 1982, 21 (3) 694-700;
You have access
1H Fourier transform nuclear magnetic resonance relaxation rate studies on the interaction of acetanilide with purified isozymes of rabbit liver microsomal cytochrome P-450 and with cytochrome b5.
R F Novak and K P Vatsis

Molecular Pharmacology May 1982, 21 (3) 701-709;
You have access
Reductive metabolism of halothane by human and rabbit cytochrome P-450. Binding of 1-chloro-2,2,2-trifluoroethyl radical to phospholipids.
J R Trudell, B Bösterling and A J Trevor

Molecular Pharmacology May 1982, 21 (3) 710-717;
You have access
Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
D S Rosenblatt, V M Whitehead, N V Matiaszuk, A Pottier, M J Vuchich and D Beaulieu

Molecular Pharmacology May 1982, 21 (3) 718-722;
You have access
Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells.
W L Washtien

Molecular Pharmacology May 1982, 21 (3) 723-728;
You have access
Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards.
K D Tew and A L Wang

Molecular Pharmacology May 1982, 21 (3) 729-738;
You have access
Morphological transformation, DNA strand separation, and antinucleoside immunoreactivity following exposure of cells to intercalating drugs.
S Neubort, D Liebeskind, F Mendez, F Elequin, K C Hsu and R Bases

Molecular Pharmacology May 1982, 21 (3) 739-743;
You have access
Neonatal imprinting and hepatic cytochrome P-450. Immunochemical evidence for the presence of a sex-dependent and neonatally imprinted form(s) of hepatic cytochrome P-450.
H Chao and L W Chung

Molecular Pharmacology May 1982, 21 (3) 744-752;
You have access
Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 alpha-carbonitrile or other steroidal or non-steroidal agents.
D M Heuman, E J Gallagher, J L Barwick, N A Elshourbagy and P S Guzelian

Molecular Pharmacology May 1982, 21 (3) 753-760;